Peterson B, Arzika AM, Amza A, Maliki R, Karamba AMankara, Moussa M, Kemago M, Liu Z, Houpt E, Liu J et al..  2024.  Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial.. Clin Infect Dis. 

O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.

Doan T, Liu Z, Sie A, Dah C, Bountogo M, Ouattara M, Coulibaly B, Kiemde D, Zonou G, Nebie E et al..  2024.  Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg. 

Ousmane S, Kollo IA, Jambou R, Boubacar R, Arzika AM, Maliki R, Amza A, Liu Z, Lebas E, Colby E et al..  2023.  Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study.. Am J Trop Med Hyg. 

Redd TK, Lalitha P, N Prajna V, Sikha M, Gunasekaran R, Hinterwirth A, Chen C, Zhong L, Liu Z, Lietman TM et al..  2022.  Impact of Sample Collection Order on the Diagnostic Performance of Metagenomic Deep Sequencing for Infectious Keratitis.. Cornea. 41(1):39-44.

O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.

Lalitha P, N Prajna V, Sikha M, Gunasekaran R, Hinterwirth A, Worden L, Chen C, Zhong L, Liu Z, Lietman TM et al..  2020.  Evaluation of Metagenomic Deep Sequencing as a Diagnostic Test for Infectious Keratitis.. Ophthalmology.